Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Gastrointestinal 4Other solid neoplasm 3Genitourinary 3Other 2Dermatologic 2Other neoplasm 1Other hematologic neoplasm 1Gynecologic 1

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Kidney Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Paclitaxel 39Specimen Handling 32Carboplatin 32pembrolizumab 31Bevacizumab 24Magnetic Resonance Spectroscopy 23Gemcitabine 15Biopsy 15liposomal doxorubicin 14olaparib 13Cisplatin 11Nivolumab 9Doxorubicin 9Topotecan 8Taxes 8Cyclophosphamide 8fludarabine 7palbociclib 6Surveys and Questionnaires 6Fulvestrant 6lenvatinib 5abemaciclib 5X-Rays 5Immunoglobulin G 5Docetaxel 5Disulfides 51-dodecylpyridoxal 5trastuzumab deruxtecan 4mirvetuximab soravtansine 4dostarlimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Methods × Gynecologic × 30 days × Clear all
NCT05056077 2026-05-18

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡